Canadian Medical Cannabis Company, Zenabis, Fails Maltese Standards Inspection

Canadian Medical Cannabis Company, Zenabis, Fails Maltese Standards Inspection

Here’s what  LovinMalta are reporting about Zenabis & their aim to set up in Malta as a way of accessing the EU market.   One of the major Canadian companies hoping to set up shop in Malta has run into an obstacle after it failed a GMP (good manufacturing practice) inspection on their Delta, British Colombia facility. A “statement of non-compliance” was published by Maltese regulators last December, where Zenabis was found to not have complied with the European Union’s GMP requirements. Zenabis was found to have failed to have achieved a “correctly implemented pharmaceutical quality system” – a critical deficiency – as well as another 29 other red flags, nine of them being considered “major”. Following the failed inspection, the company had sent in a “corrective and preventive action” plan to sort out the issues raised in the failed inspection – but Zenabis never followed through on their own plans. “The company failed to follow-up on this plan and to meet the commitments made. The company changed its plans and no longer actively rectified the deficiencies to come in line with EU-GMP according to the mutually agreed reasonable time-frame,” a report published on EudraGMDP, the online database run by…

Excerpt only …
READ MORE BELOW
Source : CANNANNEW REPORT
Link to original : Canadian Medical Cannabis Company, Zenabis, Fails Maltese Standards Inspection
reposted by Cannabis News World

This site uses Akismet to reduce spam. Learn how your comment data is processed.